Many men with prostate cancer say that changes to their sex life are the biggest issue they have to deal with. This booklet explains how prostate cancer and its treatment can affect your sex life, how you feel about yourself and any relationships you have. It explains the treatment and support that is available. The DVD features six men talking about how they are dealing with changes to their sex life during and after treatment for prostate cancer.

This booklet includes the information in the Sex and prostate cancer fact sheet, so you don’t need to order both.

Last updated: January 2015
To be reviewed: January 2017

References  

  • Abdollah F, Sun M, Suardi N et al. Prediction of functional outcomes after nerve-sparing radical prostatectomy: Results of conditional survival analyses. European Urology. 2012. Doi:10.1016/j.eururo.2012.02.057
  • Arackel BS, Benegal V. Prevalence of sexual dysfunction in male subjects with alcohol dependence. Indian J Psychiatry 2007;49(2):109–12. doi: 10.4103/0019-5545.33257
  • Barnas JL, Pierpaoli S, Ladd P, et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int 2004;94(4):603–5.
  • Basal S, Wambi C, Acikel C, et al. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function. BJU Int 2013;111(4):658-65.
  • Basal S, Wambi C, Acikel C, et al. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function. BJU Int 2013;111(4):658-65.
  • Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag 2009;5:427–48.
  • Baumann FT. Zopf EM. Bloch W. Clinical exercise interventions in prostate cancer patients--a systematic review of randomized controlled trials. [Review] Supportive Care in Cancer. 2012;20(2):221-33,
  • Beck AM, Robinson JW, Carlson LE. Sexual intimacy in heterosexual couples after prostate cancer treatment: What we know and what we still need to learn. Urol Oncol 2009;27(2):137-43.
  • Berkley FJ. Managing the adverse effects of radiation therapy. Am Fam Physician 2010;82(4):381–88.
  • Berookhim BM, Nelson CJ, Kunzel B, et al. Prospective analysis of penile length changes after radical prostatectomy. BJU Int 2014;113(5b):E131-6
  • Blank TO. Gay men and prostate cancer: invisible diversity. J Clin Oncol 2005;23:2593.
  • Boehmer D, Badakhshi H, Kuschke W et al. Testicular Dose in Prostate Cancer Radiotherapy: Impact on Impairment of Fertility and Hormonal Function. Strahlenther Onkol 2005:181(3):179-84.
  • Botrel TE, Clark O, dos Reis Rb, et al. Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis. BMC Urol 2014.
  • Campbell LC, Keefe FJ, McKee DC, et al. Masculinity beliefs predict psychosocial functioning in African American prostate cancer survivors. Am J Mens Health 2012;6(5):400-8.
  • Canada AL, Neese LE, Sui D, Schover LR. Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer 2005;104(12):2689-700.
  • Cao S, Yin X, Wang Y, et al. Smoking and Risk of Erectile Dysfunction: Systematic Review of Observational Studies with Meta-Analysis. PLoS One 2013;8(4):e60443.
  • Caverject 5 micrograms powder for solution for injection: Summary of Product Characteristics. Electronic Medicines Compendium. Last updated 2 January 2013. Available at: www.medicines.org.uk/emc/medicine/1480
  • Chen LN, Suy S, Uhm S, et al. Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiation Oncol 2013;8:58
  • Choi JM, Nelson CJ, Stasi J, Mulhall JP. Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J Urol 2007;177(6):2223-6.
  • Cialis 2.5mg, 5mg, 10mg & 20mg film-coated tablets: Summary of Product Characteristics. Electronic Medicines Compendium. Last updated 3 April 2013. Available at: www.medicines.org.uk/emc/medicine/11363
  • Cornell D. A gay urologist’s changing views of prostate cancer. J Gay & Lesbian Psychotherapy 2005;9(1-2):29–41.
  • Corona G, Rastrelli G, Filippi S, et al. Erectile dysfunction and central obesity: an Italian perspective. Asian J Androl 2014;16(4):581-91.
  • Counterfeit medicines. World Health Organization. Available from:www.who.int/medicines/services/counterfeit/overview/en/, accessed 15 September 2014
  • Dalkin BL, Christopher BA. Preservation of penile length after radical prostatectomy: early intervention with a vacuum erection device. Int J Impot Res 2007;19(5):501-4.
  • DeLamater J, Karraker A. Sexual functioning in older adults. Curr Psychiatry Rep 2009;11(1):6-11.
  • Erectile Dysfunction Clinic – What happens. Queen Elizabeth Hospital Birmingham. August 2012.
  • Ervik B, Asplund K. Dealing with a troublesome body: A qualitative interview study of men’s experiences living with prostate cancer treated with endocrine therapy. Eur J Oncol Nurs 2012;16(2):103-08.
  • Ervik B, Nordøy T, Asplund K. In the Middle and on the Sideline: The experience of spouses of men with prostate cancer. Cancer Nurs 2013;36(3):E7-E14.
  • Freezing and storing sperm. Human Fertilisation and Embryology Authority. Available at www.hfea.gov.uk, accessed 25 September 2014.
  • Gacci M, Baldi E, Tamburrion L, et al. Sexuality of Life and Sexual Health in the Aging of PCa Survivors. Int J Endocrinol 2014.
  • Gades NM, Nehra A, Jacobson DJ, et al. Association between smoking and erectile dysfunction: a population-based study. Am J Epidemiol 2005;161(4):346-51.
  • Garcia FJ, Brock G. Current state of penile rehabilitation after radical prostatectomy. Current Opinion in Urology 2010;20:234-40.
  • Goldstone SE. The ups and downs of gay sex after prostate cancer treatment. J Gay & Lesbian Psychotherapy 2005;9(1-2):43–55.
  • Guidelines on the management of erectile dysfunction. British Society for Sexual Medicine (BSSM). September 2013.
  • Haliloglu A, Baltaci S, and Yaman O. Penile Length Changes in Men Treated With Androgen Suppression Plus Radiation Therapy for Local or Locally Advanced Prostate Cancer. J Urol 2007;77:128-30.
  • Hannan JL, Maio MT, Komolova M, Adams MA. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. J Sexual Med 2009;6(Suppl 3):254-61.
  • Ilie CP, Mischianu DL, Pemberton RJ. Painful ejaculation. BJU Int 2007;99(6):1335-39.
  • International Commission on Radiological Protection. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98. Ann ICRP. 2005;35(3):iii-vi, 3-50.
  • Joniau S, Mason MD, Matveev V,et al. Guidelines on Prostate Cancer. European Association of Urology 2014.
  • Kazer MW, Harden J, Burke M, et al. The experiences of unpartnered men with prostate cancer: a qualitative analysis. J Cancer Survivorship 2011;5:132-41.
  • Keogh JW, MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. [Review] J Pain & Symptom Management 2012;43(1):96-110.
  • Khasksar SJ, Laing RW, Langley SE. Fertility after prostate brachytherapy BJU Int 2005;96(6):915.
  • Kilminster S, MüllerS, MenonM, et al. Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. BJU Int 2012;110:422–26.
  • Kimura M, Caso JR, Banez LL, et al. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy. BJU Int 2012;110(11):E931-8.
  • Kirby MG, White ID, Butcher J, et al. Development of UK recommendations on treatment for post-surgical erectile dysfunction. Int J Clin Pract 2014;68:590–608.
  • Knight SJ, Latini DM. Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences. Cancer 2009;15(1):41-44.
  • Kyrdalen AE, Dahl AA, Hernes E, et al. Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis 2010;13:144-50.
  • Latini D M, hart SL, Coon DW, Knight SJ. Sexual rehabilitation after localised prostate cancer: current interventions and future directions. Cancer J 2009;15(1):34-40.
  • Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17(1):39-57.
  • Laurent SM, Simons AD. Sexual dysfunction in depression and anxiety: Conceptualizing sexual dysfunction as part of an internalizing dimension. Clin Psychol Rev 2009;29:573-85.
  • Lee J, Hersey K, Lee CT, et al. Climacturia following radical prostatectomy: prevalence and risk factors. J Urol 2006;176:2562-5.
  • Letts C, Tamlyn K, Byers S. Exploring the impact of prostate cancer on men’s sexual well-being. J Psychosocial Oncol 2010;28:490-510.
  • Levinson AW, Lavery HJ, Ward NT et al. Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy. World J Urol 2011;29:29–34.
  • Lukka H, Waldron T, Chin J, et al. High-intensity Focused Ultrasound for Prostate Cancer: a Systematic Review. Clin Oncol 2011;23:117-27.
  • McCabe M, Althof SE, Assalian P, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sexual Med 2010;7:327–36.
  • McKee AL, Schover LR. Sexuality rehabilitation. Cancer Supplement: Cancer Rehabilitation in the New Millenium. Cancer 2001;92:1008-11.
  • Meldrum DR, Gambone JC, Morris MA, et al. Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res 2012;24:61-68.
  • Mohan R, Schellhammer PF. Treatment options for localized prostate cancer. Am Fam Physician2011;84(4):413–20.
  • Molton IR, Siegel SD, Penedo FJ, et al. Promoting recovery of sexual functioning after radical prostatectomy with group based stress management: the role of interpersonal sensitivity. J Psychosom Res 2008;64(5):527-36.
  • Morgentaler A. Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol 2013;189(1):S26-33.
  • Mottet N, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer. European Association of Urology. April 2014.
  • MUSE 100 micrograms urethral stick. Summary of Product Characteristics. Electronic Medicines Compendium. Last updated 9 January 2014. Available at: www.medicines.org.uk/emc/medicine/22218
  • Mydlo JH, Lebed B. Does brachytherapy of the prostate affect sperm quality and/or fertility in younger men? Scandinavian J Urology & Nephrology 2004;38(3):221-4.
  • National Institute for Clinical Excellence. Cryotherapy for recurrent prostate cancer. Interventional procedure guidance 119. 2005
  • National Institute for Health and Clinical Excellence. High dose rate brachytherapy in combination with external beam radiotherapy for localised prostate cancer. NICE interventional procedure guidance 174. 2006.
  • National Institute for Health and Clinical Excellence. High dose rate brachytherapy in combination with external beam radiotherapy for localised prostate cancer. NICE interventional procedure guidance 174. 2006.
  • Potosky AL, Knopf K, Clegg LX, et al. Quality-of-Life outcomes after primary androgen deprivation therapy: results from the prostate cancer outcomes study. J Clin Oncol 2001;19(17):3750-57.
  • Press release: MHRA warns about dangerous ‘herbal’ treatments. Medicines and Healthcare products Regulatory Agency (MHRA). www mhra gov uk. 30 June 2011.Available from: www.mhra.gov.uk/NewsCentre/Pressreleases/CON120474
  • Prostate cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence (NICE). Clinical guideline 175. January 2014.
  • Prue G, Rankin J, Allen J, et al. Cancer-related fatigue: A critical appraisal. Eur J Cancer 2006;42:846-63.
  • Raina R, Pahlajani G, Agarwal A, Zippe CD. Early penile rehabilitation following radical prostatectomy: Cleveland clinic experience. Int J Clin Pract 2008;20:121–26.
  • Reese JB, Keefe FJ, Somers TJ, Abernethy AP. Coping with sexual concerns after cancer: the use of flexible coping. Support Care Cancer 2010;18(7):785-800.
  • Reese JB. Coping with sexual concerns after cancer. Curr Opin Oncol 2011;23(4):313-21.
  • Research into the differential needs of men with prostate cancer at different life stages. A report prepared for Prostate Cancer UK by BritainThinks. March 2014
  • Rivers BM, August EM, Gwede CK, et al. Psychosocial issues related to sexual functioning among African-American prostate cancer survivors and their spouses. Psycho-Oncol 2011;20(1):106-10.
  • Saitz TR,Serefoglu EC,Trost LW, et al.The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer.Androl 2013;1(6):859-63.
  • Salonia A, Eardley I, Giuliano F, et al. European Association of Urology guidelines on priapism. [Review] European Urol 2014;65(2):480-9.
  • Schmitt B, Bennett C, Seidenfeld J, et al. Maximal androgen blockade for advanced prostate cancer. Cochrane Database of Systematic Reviews 1999, Issue 2.
  • Schover LR, Canada AL, Yuan Y, et al. A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer 2012;118(2):500-9.
  • Siegel AL. Pelvic floor muscle training in males: practical applications. Urol 2014;84(1):1-7.
  • Sildenafil 100 mg film-coated tablets: Summary of Product Characteristics. Electronic Medicines Compendium. Last updated 16 June 2014. Available at: www.medicines.org.uk/emc/medicine/27846
  • Thomas C, Wootten A, Robinson P. The experiences of gay and bisexual men diagnosed with prostate cancer: results from an online focus group. Eur J Cancer Care 2013;22:522-29.
  • Topical alprostadil cream: Summary of Product Characteristics. Electronic Medicines Compendium. Last updated 17 October 2014. Available at: https://www.medicines.org.uk/emc/medicine/28866
  • Walker LM, Robinson JW. The unique needs of couples experiencing androgen deprivation therapy for prostate cancer. Sex Marital Therapy 2010;36:154-65.
  • Walsh PC. Re: Orgasm associated urinary incontinence and sexual life after radical prostatectomy. J Urol 2012;187(2):501.
  • Wespes E, Eardley I, Giuliano F, et al. Guidelines on Male Sexual Dysfunction. European Association of Urology. 2013
  • What is psychosexual therapy? Porterbrook Clinic. Sheffield NHS Trust. 2006
  • White ID, Wilson J, Aslet P, et al. Development of UK guidance on the management of erectile dysfunction (ED) resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer. Int J Clin Pract 2014
  • Wittmann D, Northouse L, Foley S, et al. The psychosocial aspects of sexual recovery after prostate cancer treatment. Int J Impot Res 2009;21(2):99-106.
  • Zaorsky NG, Doyle LA, Yamoah K, et al. High dose rate brachytherapy boost for prostate cancer: A systematic Review. Cancer Treatment Reviews 2014;(40):414–25.
  • Zippe CD, Pahlajani G. Vacuum erection devices to treat erectile dysfunction and early penile rehabilitation following radical prostatectomy. Curr Urol Reports 2008;9:5006-13.

Order printed copies of this publication

Before you order we would like to know who you are, and why you are ordering printed copies.

Download digital versions of this publication